Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
RENEO PHARMACEUTICALS INC
RPHM·75974E103·UV·Common Stock
RPHM (RENEO PHARMACEUTICALS INC) is held by 0 institutional investors as of Q4 2024.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold RPHM.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $4.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $384,710 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $13,036 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $852,608 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $0 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $33,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $364,726 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $853 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2,007 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2,061 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $906 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $389 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $18,758 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $6,042 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $24,030 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $16,184 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $100,624 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2,594 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $84,701 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $204,960 | 0.0% | — | 0 |
Showing 1-20 of 29
1 / 2
RPHMRENEO PHARMACEUTICALS INCContinue exploring
Similar stocks
FISVFiserv Inc334 holders · $21.5B
SPYSPDR S&P 500 ETF Trust294 holders · $348.2B
IVViShares Core S&P 500 ETF262 holders · $566.9B
QQQInvesco QQQ Trust Series 1246 holders · $125.8B
VOOVANGUARD S&P500 INDEX ETF245 holders · $264.7B
IWMiShares Russell 2000 ETF242 holders · $68.1B
GLDSPDR GOLD TRUST GOLD SHS237 holders · $34.1B
XLFFinancial Select Sector SPDR Fund224 holders · $31.5B
XLEEnergy Select Sector SPDR Fund223 holders · $17.3B
EFAiShares MSCI EAFE ETF221 holders · $47.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer